Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-044662

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher Haqq
Officer — Chief Medical Officer
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 15, 2015M4,422$0.00A266,052D
Common StockMay 15, 2015F1,887$37.30D264,165D
Common StockF2holding———20,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—May 15, 2015M4,422D——Common Stock4,4228,844D

Explanation of responses